Janux Therapeutics, Inc. (JANX)
NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
As of 10:30AM EDT. Market open.
Currency in USD
Valuation Measures4
| Market Cap (intraday) | 2.90B |
| Enterprise Value | 2.58B |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 305.39 |
| Price/Book (mrq) | 8.41 |
| Enterprise Value/Revenue | 318.89 |
| Enterprise Value/EBITDA | -36.29 |
Trading Information
Stock Price History
| Beta (5Y Monthly) | 4.18 |
| 52-Week Change 3 | 277.39% |
| S&P500 52-Week Change 3 | 24.19% |
| 52 Week High 3 | 61.00 |
| 52 Week Low 3 | 5.65 |
| 50-Day Moving Average 3 | 39.50 |
| 200-Day Moving Average 3 | 17.27 |
Share Statistics
| Avg Vol (3 month) 3 | 978.83k |
| Avg Vol (10 day) 3 | 728.51k |
| Shares Outstanding 5 | 51.66M |
| Implied Shares Outstanding 6 | 51.66M |
| Float 8 | 18.61M |
| % Held by Insiders 1 | 13.78% |
| % Held by Institutions 1 | 83.28% |
| Shares Short (Apr 15, 2024) 4 | 3.44M |
| Short Ratio (Apr 15, 2024) 4 | 4.49 |
| Short % of Float (Apr 15, 2024) 4 | 14.23% |
| Short % of Shares Outstanding (Apr 15, 2024) 4 | 6.66% |
| Shares Short (prior month Mar 15, 2024) 4 | 3.11M |
Dividends & Splits
| Forward Annual Dividend Rate 4 | N/A |
| Forward Annual Dividend Yield 4 | N/A |
| Trailing Annual Dividend Rate 3 | 0.00 |
| Trailing Annual Dividend Yield 3 | 0.00% |
| 5 Year Average Dividend Yield 4 | N/A |
| Payout Ratio 4 | 0.00% |
| Dividend Date 3 | N/A |
| Ex-Dividend Date 4 | N/A |
| Last Split Factor 2 | N/A |
| Last Split Date 3 | N/A |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | Dec 31, 2023 |
| Most Recent Quarter (mrq) | Dec 31, 2023 |
Profitability
| Profit Margin | 0.00% |
| Operating Margin (ttm) | -655.71% |
Management Effectiveness
| Return on Assets (ttm) | -12.25% |
| Return on Equity (ttm) | -17.53% |
Income Statement
| Revenue (ttm) | 8.08M |
| Revenue Per Share (ttm) | 0.18 |
| Quarterly Revenue Growth (yoy) | -13.50% |
| Gross Profit (ttm) | N/A |
| EBITDA | -71.02M |
| Net Income Avi to Common (ttm) | -58.29M |
| Diluted EPS (ttm) | -1.32 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 344.03M |
| Total Cash Per Share (mrq) | 6.66 |
| Total Debt (mrq) | 24.54M |
| Total Debt/Equity (mrq) | 7.13% |
| Current Ratio (mrq) | 26.80 |
| Book Value Per Share (mrq) | 7.45 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -50.58M |
| Levered Free Cash Flow (ttm) | -29.52M |
© 2024 Yahoo. All rights reserved.